BPTH on OTC

BIO-PATH HOLDINGS, INC.

Price unavailable

Last updated Oct 16, 2026.

Overview

Compare with ORAGENICS INC, Lyell Immunopharma, Inc. or AXIM BIOTECHNOLOGIES, INC., or pick any stock.

  • TickerBPTH on OTC
  • IndustryPharmaceutical Preparations
  • HeadquartersWY
  • Incorporated inWY2
  • Business address4710 Bellaire Boulevard, Suite 210, Bellaire, Tx 774012
  • Filer categoryNon-accelerated filer, Smaller reporting company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2018

-704.7%Return on equity3
-$6.1MFree cash flow4

Financial statements

Fiscal year2018
Revenue$05
Research and development$4.6M4
Operating income-$8.6M4
Income tax$04
Net income-$8.6M4
Earnings per share
Earnings per share (diluted)

Compare BIO-PATH HOLDINGS, INC. with another company

Former names

  • BIO-PATH HOLDINGS INCDec 27, 2006 to Apr 5, 20242
  • OGDEN GOLF CO CORPMay 8, 2003 to Feb 19, 20082

Recent filings

  1. Aug 20, 20261-SA SEMI ANNUAL REPORT PURSUANT TO REGULATION A
  2. Aug 5, 2026253G2 OFFERING CIRCULAR SUPPLEMENT NO. 1
  3. Jul 16, 20268-K
  4. May 26, 20268-K
  5. May 22, 202615-12G FORM 15
  6. May 20, 202610-Q
  7. May 15, 2026NT 10-Q
  8. May 1, 20261-K
  9. Apr 28, 2026QUALIF
  10. Apr 27, 2026CORRESP
  11. Apr 1, 2026UPLOAD
  12. Mar 25, 20261-A
  13. Mar 20, 20268-K
  14. Feb 25, 20261-Z
  15. Feb 24, 20268-K

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1